FDA Inspection 1111273 — University of Louisville Biomedical Institutional Review Board
The FDA completed an inspection of University of Louisville Biomedical Institutional Review Board on October 9, 2019 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 9, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Louisville, KY (United States)
Additional Details
IRB